Lataa...
Serum Procalcitonin in Patients With Combined Lung Cancer and Idiopathic Pulmonary Fibrosis (LC-IPF)
Background Procalcitonin (PCT) is a potential biomarker for sepsis and acts as a guide to antibiotic administration. Previous studies showed that lung cancer (LC) may increase serum PCT levels. However, no studies addressed serum PCT in patients with combined LC and idiopathic pulmonary fibrosis (IP...
Tallennettuna:
| Julkaisussa: | Cureus |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Cureus
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7458704/ https://ncbi.nlm.nih.gov/pubmed/32879828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9507 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|